Skip to main content
Log in

Investigations of the effects of ethanol on warfarin binding to human serum albumin

  • Original Paper
  • Published:
Journal of Biomedical Science

Abstract

Ethanol effects on warfarin binding to human serum albumin (HSA) have been studied by equilibrium dialysis and fluorescence methods at pH 7.4 in phosphate-buffered saline at 37°C. In the presence of various amounts of ethanol fluorescence intensity of bound warfarin decreased significantly but this intensity reduction was not solely from displacement of bound warfarin from HSA. By comparing fluorescence and equilibrium dialysis data we concluded that fluorescence intensity reduction of warfarin was mainly the result of changes in the surrounding environment of the warfarin binding site by ethanol interaction with HSA and that displacement of bound warfarin was not significant compared to the fluorescence intensity changes. The dissociation constant of warfarin binding to HSA decreased with an increasing amount of ethanol. From the changes in fluorescence intensity upon warfarin binding to HSA with the presence of ethanol ranging from 0 to 5.0% the following dissociation constants (Kd) were determined: 0% ethanol 5.39 ± 0.2 µM, 0.1% ethanol 5.86 ± 0.1 µM, 0.3% ethanol 5.83 ± 0.2 µM, 0.5% ethanol 6.76 ± 0.1 µM, 1% ethanol 7.01 ± 0.1 µM, 3% ethanol 9.9 ± 0.7 µM, 5% ethanol 13.01 ± 0.1 µM. From the equilibrium dialysis with the same ranges of ethanol presence the following Kd values were obtained: 0% ethanol 6.62 ± 1.6 µM, 0.1% ethanol 6.81 ± 1.1 µM, 0.3% ethanol 8.26 ± 2.5 µM, 0.5% ethanol 8.86 ± 1.9 µM, 1% ethanol 11.01 ± 4.2 µM, 3% ethanol 20.75 ± 2.4 µM, 5% ethanol 21.67 ± 2.2 µM. The results suggest that warfarin bound to HSA was displaced by ethanol. These data indicate that ethanol influence on warfarin binding to HSA may alter the pharmacokinetics of warfarin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Adams WL. Potential for adverse drug-alcohol interactions among retirement community residents. J Am Geriatr Soc 43:1021–1025;1995.

    Google Scholar 

  2. Avdulov NA, Chochina SV, Daragan VA, Schroeder F, Mayo KH, Wood WG. Direct binding of ethanol to bovine serum albumin a fluorescent and 13C NMR multiplet relaxation study. Biochemistry 35:340–347;1996.

    Google Scholar 

  3. Avdulov NA, Wood WG, Harris RA. Effects of ethanol on structural parameters of rat brain membranes: Relationship to genetic differences in ethanol sensitivity. Alcohol Clin Exp Res 18:53–59;1994.

    Google Scholar 

  4. Chakrabarti SK. Cooperativity of warfarin binding with human serum albumin induced by free acid anion. Biochem Pharmacol 27:739–743;1978.

    Google Scholar 

  5. Deitrich RA, Dunwiddie TV, Harris RA, Erwin VG. Mechanism of action of ethanol: Initial central nervous system actions. Pharmacol Rev 41:489–537;1989.

    Google Scholar 

  6. Garten S, Wosilait WD. Comparative study of the binding of coumarin anticoagulants and serum albumins. Biochem Pharmacol 20:1661–1668;1971.

    Google Scholar 

  7. Harder S, Thurman P, Clinically important drug interactions with anticoagulants. An update. Clin Pharmacokinet 30:416–444;1996.

    Google Scholar 

  8. He XM, Carter DC. Atomic structure and chemistry of human serum albumin. Nature 358;209–215;1992.

    Google Scholar 

  9. Jones AW. The drunkest drinking driver in Sweden: Blood alcohol concentration 0.545%, w/v. J Stud Alcohol 60:400–406;1999.

    Google Scholar 

  10. Larsen FG, Larsen CG, Jakobsen P, Brodersen R. Interaction of warfarin with human serum albumin. Mol Pharmacol 27:263–270;1984.

    Google Scholar 

  11. Li C, Peoples RW, Weight FF. Alcohol action on a neuronal membrane receptor: Evidence for a direct interaction with the receptor protein. Proc Natl Acad Sci USA 91:8200–8204;1994.

    Google Scholar 

  12. Lubas B, Soltysik-Rasek M, Lesniewska I. Proton nuclear magnetic resonance study of the association of monovalent and divalent alcohols with bovine serum albumin. Biochemistry 18:4943–4951;1979.

    Google Scholar 

  13. Maclaren R, Wachsman BA, Swift DK, Kuhl DA. Warfarin resistance associated with intravenous lipid administration: Discussion of propofol and review of the literature. Pharmacotherapy 17:1331–1337;1997.

    Google Scholar 

  14. Maes V, Engelborghs Y, Hoebeke J, Maras Y, Vercruysse A. Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study. Mol Pharmacol 21:100–107;1982.

    Google Scholar 

  15. Ogiso T, Iwaki M, Konishi Y. Effect of furosemide on plasma clearance, anticoagulant effect and protein binding of warfarin in rats. J Pharmacobiodyn 5:829–840;1982.

    Google Scholar 

  16. O'Reilly RA, Kowitz PE. Studies on the coumarin anticoagulant drugs: Interaction of human plasma albumin and warfarin sodium. J Clin Invest 46:829–837;1967.

    Google Scholar 

  17. Orr A, Ivanova VS, Bonner WM. ‘Water-bug’ dialysis technique. Biotechniques 19/2:204;1995.

    Google Scholar 

  18. Pinkerton TC, Koeplinger KA. Determination of warfarin-human serum albumin protein binding parameters by an improved Hummel-Dreyer high-performance liquid chromatographic method using internal surface reversed-phase columns. Anal Chem 62:2114–2122;1990.

    Google Scholar 

  19. Sioris LJ, Weibert RT, Pentel PR. Potentiation of warfarin anticoagulation by sulfisoixazole. Arch Intern Med 140:546–547;1980.

    Google Scholar 

  20. Slater SJ, Cox KJA, Lombardi JV, Ho C, Kelly MB, Rubin E, Stubbs CD. Inhibition of protein kinase C by alcohols and anaesthetics. Nature 364:82–84;1993.

    Google Scholar 

  21. Sudlow G, Birkett DJ, Wade DN. The characterization of two specific drug binding sites on human serum albumin. Mol Pharmacol 11:824–832;1975.

    Google Scholar 

  22. Sudlow G, Birkett DJ, Wade DN. Further characterization of specific drug binding sites on human serum albumin. Mol Pharmacol 12:1052–1061;1976.

    Google Scholar 

  23. Taira Z, Terada H. Specific and non-specific ligand binding to serum albumin. Biochem Pharmacol 34:1995–2005;1985.

    Google Scholar 

  24. Wilting J, van der Giesen F, Janssen LHM, Weiderman MM, Otagiri M. The effect of albumin conformation on the binding of warfarin to human serum albumin. J Biol Chem 255:3032–3037;1980.

    Google Scholar 

  25. Yacobi A, Udall JA, Levy G. Serum protein binding as a determinant of warfarin body clearance and anticoagulant effect. Clin Pharmacol Ther 19:552–558;1976.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ha, CE., Petersen, C.E., Park, D.S. et al. Investigations of the effects of ethanol on warfarin binding to human serum albumin. J Biomed Sci 7, 114–121 (2000). https://doi.org/10.1007/BF02256617

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02256617

Key Words

Navigation